Latest On Autolus Therapeutics plc (AUTL):
About Autolus Therapeutics plc (AUTL):
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company is developing AUTO1 and AUTO3 for B cell malignancies; AUTO2 and AUTO8 for the treatment of multiple myeloma; AUTO1/22 for the treatment of dual-targeting CAR-T; AUTO3NG for the treatment of hematological cancer; AUTO4 and AUTO5 for T cell lymphoma; AUTO6NG for the treatment of programmed T cell therapies; AUTO6 for the treatment of neuroblastoma; and AUTO7 for the treatment of prostate cancer. Autolus Therapeutics plc was founded in 2014 and is headquartered in London, the United Kingdom.
General
- Name Autolus Therapeutics plc
- Symbol AUTL
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 376
- Fiscal Year EndSeptember
- IPO Date2018-06-22
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.autolus.com
Valuation
- Price/Sales (Trailing 12 Mt.) 1470.04
- Price/Book (Most Recent Quarter) 2.32
- Enterprise Value Revenue 1600.67
Financials
- Most Recent Quarter 2020-12-31
- Next Quarter EPS Estimate -$0.78
- Operating Margin -6571%
- Return on Assets -22%
- Return on Equity -30%
- Revenue 1.08 million
- Earnings Per Share -$1.40
- Revenue Per Share $0.03
- Gross Profit -133173000
- Quarterly Earnings Growth 0%
Highlights
- Market Capitalization 483.68 million
- EBITDA -68942608
- Analyst Target Price $15.78
- Book Value Per Share $5.91
Share Statistics
- Shares Outstanding 70.51 million
- Shares Float 33.9 million
- % Held by Insiders 3186%
- % Held by Institutions 25.44%
- Shares Short 3.51 million
- Shares Short Prior Month 1.71 million
- Short Ratio 2.67
- Short % of Shares Outstanding 5%
Technicals
- Beta 1.75
- 52 Week High $17.19
- 52 Week Low $4
- 50 Day Moving Average 7.05
- 200 Day Moving Average 9.94
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Autolus Therapeutics plc (AUTL) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Autolus Therapeutics plc (AUTL) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2021-03-04 | $N/A | -$0.83 | -$0.77 | -8.03% |
2020-09-30 | 2020-11-05 | $N/A | -$0.72 | -$0.71 | -1.84% |
2020-06-30 | 2020-08-06 | $N/A | -$0.62 | -$0.70 | 11.29% |
2020-03-31 | 2020-05-07 | $N/A | -$0.60 | -$0.75 | 19.57% |
2019-12-31 | 2020-03-03 | $309000 | -$0.84 | -$0.74 | -14.27% |
2019-09-30 | 2019-11-07 | $297000 | -$0.61 | -$0.83 | 26.73% |
2019-06-30 | 2019-08-08 | $338000 | -$0.65 | -$0.66 | 0.76% |
2019-03-31 | 2019-05-14 | $1.96 million | -$0.69 | -$0.56 | -22.49% |
2018-12-31 | 2019-02-25 | $296000 | -$0.52 | -$0.66 | 21.21% |
Autolus Therapeutics plc (AUTL) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Autolus Therapeutics plc (AUTL) Chart:
Autolus Therapeutics plc (AUTL) News:
Below you will find a list of latest news for Autolus Therapeutics plc (AUTL) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Autolus Therapeutics plc (AUTL) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|---|---|---|---|---|---|---|---|---|
2025-04-17 | 0.5 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
2025-04-17 | 1 | 0.7 | CALL | 0 | 2 | 495.94 | TRUE | 0 | 0 |
2025-04-17 | 1.5 | 0.34 | CALL | 0 | 18 | 88.59 | TRUE | 0 | 0 |
2025-04-17 | 2 | 0.09 | CALL | 0 | 100 | 100.73 | FALSE | 0 | 0 |
2025-04-17 | 2.5 | 0 | CALL | 0 | 0 | 132.33 | FALSE | 0 | 0 |
2025-04-17 | 5 | 0 | CALL | 0 | 0 | 269.43 | FALSE | 0 | 0 |
2025-04-17 | 7.5 | 0 | CALL | 0 | 0 | 338.61 | FALSE | 0 | 0 |
2025-04-17 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2025-04-17 | 1 | 0.05 | PUT | 0 | 530 | 745.32 | FALSE | 0 | 0 |
2025-04-17 | 1.5 | 0.1 | PUT | 0 | 1 | 417.82 | FALSE | 0 | 0 |
2025-04-17 | 2 | 0 | PUT | 0 | 0 | 283.68 | TRUE | 0 | 0 |
2025-04-17 | 2.5 | 1.05 | PUT | 0 | 1 | 114.53 | TRUE | 0 | 0 |
2025-04-17 | 5 | 0 | PUT | 0 | 0 | 842.34 | TRUE | 0 | 0 |
2025-04-17 | 7.5 | 0 | PUT | 0 | 0 | 626.75 | TRUE | 0 | 0 |
2025-05-16 | 0.5 | 0 | CALL | 0 | 0 | 258.71 | TRUE | 0 | 0 |
2025-05-16 | 1 | 0 | CALL | 0 | 0 | 310.92 | TRUE | 0 | 0 |
2025-05-16 | 1.5 | 0 | CALL | 0 | 0 | 66.46 | TRUE | 0 | 0 |
2025-05-16 | 2 | 0.11 | CALL | 224 | 630 | 91.32 | FALSE | 0.11 | 0 |
2025-05-16 | 2.5 | 0.05 | CALL | 0 | 2 | 249.24 | FALSE | 0 | 0 |
2025-05-16 | 5 | 0 | CALL | 0 | 0 | 194.49 | FALSE | 0 | 0 |
2025-05-16 | 7.5 | 0 | CALL | 0 | 0 | 995.52 | FALSE | 0 | 0 |
2025-05-16 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2025-05-16 | 1 | 0 | PUT | 0 | 0 | 450.64 | FALSE | 0 | 0 |
2025-05-16 | 1.5 | 0 | PUT | 0 | 0 | 87.1 | FALSE | 0 | 0 |
2025-05-16 | 2 | 0 | PUT | 0 | 0 | 72.46 | TRUE | 0 | 0 |
2025-05-16 | 2.5 | 0 | PUT | 0 | 0 | 184.76 | TRUE | 0 | 0 |
2025-05-16 | 5 | 0 | PUT | 0 | 0 | 1016.76 | TRUE | 0 | 0 |
2025-05-16 | 7.5 | 0 | PUT | 0 | 0 | 592.98 | TRUE | 0 | 0 |
2025-06-20 | 0.5 | 2 | CALL | 0 | 1 | 194.28 | TRUE | 0 | 0 |
2025-06-20 | 1 | 0 | CALL | 0 | 0 | 109.12 | TRUE | 0 | 0 |
2025-06-20 | 1.5 | 0 | CALL | 0 | 0 | 85.26 | TRUE | 0 | 0 |
2025-06-20 | 2 | 0.15 | CALL | 0 | 100 | 82.07 | FALSE | 0 | 0 |
2025-06-20 | 2.5 | 0.1 | CALL | 0 | 157 | 87.37 | FALSE | 0 | 0 |
2025-06-20 | 5 | 0.05 | CALL | 0 | 344 | 233.49 | FALSE | 0 | 0 |
2025-06-20 | 7.5 | 0.3 | CALL | 0 | 51 | 356.61 | FALSE | 0 | 0 |
2025-06-20 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2025-06-20 | 1 | 0 | PUT | 0 | 0 | 192.54 | FALSE | 0 | 0 |
2025-06-20 | 1.5 | 0 | PUT | 0 | 0 | 165.16 | FALSE | 0 | 0 |
2025-06-20 | 2 | 0.55 | PUT | 0 | 25 | 65.78 | TRUE | 0 | 0 |
2025-06-20 | 2.5 | 0.85 | PUT | 0 | 110 | 125.91 | TRUE | 0 | 0 |
2025-06-20 | 5 | 0 | PUT | 0 | 0 | 133.94 | TRUE | 0 | 0 |
2025-06-20 | 7.5 | 0 | PUT | 0 | 0 | 173.87 | TRUE | 0 | 0 |
2025-09-19 | 0.5 | 0 | CALL | 0 | 0 | 213.67 | TRUE | 0 | 0 |
2025-09-19 | 1 | 0.91 | CALL | 0 | 14 | 83.29 | TRUE | 0 | 0 |
2025-09-19 | 1.5 | 0 | CALL | 0 | 0 | 75.35 | TRUE | 0 | 0 |
2025-09-19 | 2 | 0.36 | CALL | 0 | 64 | 121.62 | FALSE | 0 | 0 |
2025-09-19 | 2.5 | 0.29 | CALL | 0 | 162 | 96.29 | FALSE | 0 | 0 |
2025-09-19 | 5 | 0 | CALL | 0 | 0 | 111.32 | FALSE | 0 | 0 |
2025-09-19 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2025-09-19 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2025-09-19 | 1 | 0 | PUT | 0 | 0 | 115.78 | FALSE | 0 | 0 |
2025-09-19 | 1.5 | 0 | PUT | 0 | 0 | 78.66 | FALSE | 0 | 0 |
2025-09-19 | 2 | 0.58 | PUT | 0 | 37 | 48.08 | TRUE | 0 | 0 |
2025-09-19 | 2.5 | 0.8 | PUT | 0 | 11 | 96.3 | TRUE | 0 | 0 |
2025-09-19 | 5 | 0 | PUT | 0 | 0 | 496.88 | TRUE | 0 | 0 |
2025-09-19 | 7.5 | 0 | PUT | 0 | 0 | 326.63 | TRUE | 0 | 0 |
2025-12-19 | 0.5 | 1.8 | CALL | 0 | 8 | 171.49 | TRUE | 0 | 0 |
2025-12-19 | 1 | 1 | CALL | 0 | 1 | 82.36 | TRUE | 0 | 0 |
2025-12-19 | 1.5 | 0.7 | CALL | 0 | 12 | 59.55 | TRUE | 0 | 0 |
2025-12-19 | 2 | 0.7 | CALL | 0 | 45 | 106.72 | FALSE | 0 | 0 |
2025-12-19 | 2.5 | 0.3 | CALL | 0 | 441 | 95.15 | FALSE | 0 | 0 |
2025-12-19 | 5 | 0.11 | CALL | 0 | 637 | 119.46 | FALSE | 0 | 0 |
2025-12-19 | 7.5 | 0.1 | CALL | 0 | 372 | 124.63 | FALSE | 0 | 0 |
2025-12-19 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2025-12-19 | 1 | 0 | PUT | 0 | 0 | 94.91 | FALSE | 0 | 0 |
2025-12-19 | 1.5 | 0.45 | PUT | 0 | 15 | 70.07 | FALSE | 0 | 0 |
2025-12-19 | 2 | 0.75 | PUT | 0 | 42 | 86.1 | TRUE | 0 | 0 |
2025-12-19 | 2.5 | 1.1 | PUT | 0 | 160 | 80.55 | TRUE | 0 | 0 |
2025-12-19 | 5 | 3.5 | PUT | 0 | 22 | 88.53 | TRUE | 0 | 0 |
2025-12-19 | 7.5 | 0 | PUT | 0 | 0 | 115.25 | TRUE | 0 | 0 |
Latest AUTL Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 7:45 PM EST | 100 | $2.265 |
Jun 13, 2022 7:46 PM EST | 100 | $2.25 |
Jun 13, 2022 7:46 PM EST | 100 | $2.245 |
Jun 13, 2022 7:47 PM EST | 100 | $2.24 |
Jun 13, 2022 7:47 PM EST | 38 | $2.245 |
Autolus Therapeutics plc (AUTL) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-06-30 | 20-F/A | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1730463/000119312520184031/0001193125-20-184031-index.htm |
2019-07-22 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1730463/000000000019011382/0000000000-19-011382-index.htm |
2020-06-18 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1730463/000000000020005460/0000000000-20-005460-index.htm |
2020-07-09 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1730463/000000000020006207/0000000000-20-006207-index.htm |
2019-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1730463/000119312519038198/0001193125-19-038198-index.htm |
2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1730463/000119312519039614/0001193125-19-039614-index.htm |
2019-02-25 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1730463/000119312519049964/0001193125-19-049964-index.htm |
2019-03-15 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1730463/000119312519076928/0001193125-19-076928-index.htm |
2019-03-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1730463/000119312519088447/0001193125-19-088447-index.htm |
2019-04-02 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1730463/000119312519095146/0001193125-19-095146-index.htm |
2019-04-05 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1730463/000119312519099275/0001193125-19-099275-index.htm |
2019-04-08 | F-1 | Registration statement for certain foreign private issuers | https://www.sec.gov/Archives/edgar/data/1730463/000119312519100758/0001193125-19-100758-index.htm |
2019-04-08 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1730463/000119312519100812/0001193125-19-100812-index.htm |
2019-04-08 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1730463/000119312519100816/0001193125-19-100816-index.htm |
2019-04-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1730463/000119312519100854/0001193125-19-100854-index.htm |
2019-04-10 | F-1MEF | Registration statement to add securities to prior Form F-1 registration [Rule 462(b)] | https://www.sec.gov/Archives/edgar/data/1730463/000119312519103095/0001193125-19-103095-index.htm |
2019-04-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1730463/000119312519103379/0001193125-19-103379-index.htm |
2019-04-11 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1730463/000119312519103862/0001193125-19-103862-index.htm |
2019-07-17 | F-3 | Registration statement by foreign private issuers | https://www.sec.gov/Archives/edgar/data/1730463/000119312519195733/0001193125-19-195733-index.htm |
2019-07-22 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1730463/000119312519198985/0001193125-19-198985-index.htm |
2019-07-24 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1730463/000119312519201243/0001193125-19-201243-index.htm |
2020-01-22 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1730463/000119312520012120/0001193125-20-012120-index.htm |
2020-01-24 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1730463/000119312520014188/0001193125-20-014188-index.htm |
2020-01-24 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1730463/000119312520014199/0001193125-20-014199-index.htm |
2020-01-31 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1730463/000119312520021437/0001193125-20-021437-index.htm |
2020-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1730463/000119312520031373/0001193125-20-031373-index.htm |
2020-05-26 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1730463/000119312520151568/0001193125-20-151568-index.htm |
2020-06-22 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1730463/000119312520175566/0001193125-20-175566-index.htm |
2020-06-30 | 20-F/A | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1730463/000119312520184031/0001193125-20-184031-index.htm |
2020-06-30 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1730463/000119312520184048/0001193125-20-184048-index.htm |
2020-08-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1730463/000119312520231538/0001193125-20-231538-index.htm |
2020-09-18 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1730463/000119312520248586/0001193125-20-248586-index.htm |
2020-09-18 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1730463/000119312520248640/0001193125-20-248640-index.htm |
2019-01-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1730463/000121390019000521/0001213900-19-000521-index.htm |
2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1730463/000121390019002514/0001213900-19-002514-index.htm |
2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1730463/000121390019002532/0001213900-19-002532-index.htm |
2019-08-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1730463/000121390019014928/0001213900-19-014928-index.htm |
2019-09-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1730463/000121390019017502/0001213900-19-017502-index.htm |
2019-09-16 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1730463/000121390019018073/0001213900-19-018073-index.htm |
2019-09-20 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1730463/000121390019018491/0001213900-19-018491-index.htm |
2019-10-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1730463/000121390019020030/0001213900-19-020030-index.htm |
2019-10-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1730463/000121390019020032/0001213900-19-020032-index.htm |
2020-01-24 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1730463/000121390020001740/0001213900-20-001740-index.htm |
2020-04-22 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1730463/000121390020009830/0001213900-20-009830-index.htm |
2020-06-15 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1730463/000121390020015014/0001213900-20-015014-index.htm |
2020-07-06 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1730463/000121390020016740/0001213900-20-016740-index.htm |
2020-07-20 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1730463/000121390020017961/0001213900-20-017961-index.htm |
2020-08-03 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1730463/000121390020019894/0001213900-20-019894-index.htm |
2020-08-13 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1730463/000121390020021871/0001213900-20-021871-index.htm |
2020-03-03 | 20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1730463/000162828020002797/0001628280-20-002797-index.htm |
2019-02-25 | 20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1730463/000173046319000004/0001730463-19-000004-index.htm |
2019-05-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1730463/000173046319000008/0001730463-19-000008-index.htm |
2019-08-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1730463/000173046319000011/0001730463-19-000011-index.htm |
2019-11-07 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1730463/000173046319000013/0001730463-19-000013-index.htm |
2020-05-07 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1730463/000173046320000003/0001730463-20-000003-index.htm |
2020-08-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1730463/000173046320000008/0001730463-20-000008-index.htm |
2020-11-05 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1730463/000173046320000011/0001730463-20-000011-index.htm |
2019-04-10 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1730463/999999999519000665/9999999995-19-000665-index.htm |
2019-07-24 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1730463/999999999519001680/9999999995-19-001680-index.htm |